115 related articles for article (PubMed ID: 3125619)
1. [Changes in isoagglutinin titers after high-voltage therapy with the large-field technic in Hodgkin's disease patients].
Krüsmann W; Slanina J; Wannenmacher M; Nolte I
Strahlenther Onkol; 1988 Feb; 164(2):79-84. PubMed ID: 3125619
[TBL] [Abstract][Full Text] [Related]
2. Alterations of IgE immunoglobulin concentration in the serum after megavoltage radiotherapy with large-field technique in patients with Hodgkin's disease.
Krüsmann W; Slanina J; Nolte I
Strahlenther Onkol; 1990 Apr; 166(4):265-70. PubMed ID: 2109876
[TBL] [Abstract][Full Text] [Related]
3. [Changes in concentrations of IgM, IgA and IgM immune globulins after megavolt therapy with the large-field technic in patients with Hodgkin's disease].
Krüsmann W; Slanina J; Boser F; Löhr GW
Strahlenther Onkol; 1988 Jun; 164(6):323-9. PubMed ID: 3133799
[TBL] [Abstract][Full Text] [Related]
4. ABO-incompatible kidney transplantation using antigen-specific immunoadsorption and rituximab: a single center experience.
Donauer J; Wilpert J; Geyer M; Schwertfeger E; Kirste G; Drognitz O; Walz G; Pisarski P
Xenotransplantation; 2006 Mar; 13(2):108-10. PubMed ID: 16623802
[TBL] [Abstract][Full Text] [Related]
5. Anti-A isoagglutinin as a risk factor for the development of pure red cell aplasia after major ABO-incompatible allogeneic bone marrow transplantation.
Lee JH; Lee KH; Kim S; Lee JS; Kim SH; Kwon SW; Kim WK
Bone Marrow Transplant; 2000 Jan; 25(2):179-84. PubMed ID: 10673677
[TBL] [Abstract][Full Text] [Related]
6. ABO blood groups and isoagglutinins in systemic lupus erythematosus.
Ottensooser F; Leon N; de Almeida TV
Rev Bras Pesqui Med Biol; 1975; 8(5-6):421-5. PubMed ID: 1241149
[TBL] [Abstract][Full Text] [Related]
7. [Questions and aspects of radiotherapy of adult patients with localized supradiaphragmatic stage (CS I/II) Hodgkin's disease. 1. Questions and aspects on indications for primary and adjuvant radiotherapy].
Glanzmann C; Lütolf UM
Strahlenther Onkol; 1993 Aug; 169(8):449-58. PubMed ID: 8356505
[TBL] [Abstract][Full Text] [Related]
8. Immunological characterization of Hodgkin's and non-Hodgkin's lymphoma patients with high antibody titers against Epstein-Barr virus-associated antigens.
Masucci G; Mellstedt H; Masucci MG; Szigeti R; Ernberg I; Björkholm M; Tsukuda K; Henle G; Henle W; Pearson G
Cancer Res; 1984 Mar; 44(3):1288-300. PubMed ID: 6318984
[TBL] [Abstract][Full Text] [Related]
9. Successful ABO incompatible living donor liver transplantation in a patient with high isoagglutinin titer using high-dose intravenous immunoglobulin.
Ikegami T; Taketomi A; Soejima Y; Iguchi T; Sanefuji K; Kayashima H; Yoshizumi T; Harada N; Maehara Y
Transplant Proc; 2007 Dec; 39(10):3491-4. PubMed ID: 18089417
[TBL] [Abstract][Full Text] [Related]
10. Increased but stable isoagglutinin titers in hemodialysis patients.
Assing K; Sprogoe U; Nielsen C; Rasmussen M; Yazer M; Bistrup C
J Nephrol; 2019 Feb; 32(1):121-127. PubMed ID: 30066253
[TBL] [Abstract][Full Text] [Related]
11. [Blood group isoagglutinins and immunoglobulins (IgG, IgM) in old age].
Petzl DH; Tanew A
Wien Klin Wochenschr; 1985 Jul; 97(14):595-602. PubMed ID: 3931360
[TBL] [Abstract][Full Text] [Related]
12. Relapse and late complications in early-stage Hodgkin's disease patients with mediastinal involvement treated with radiotherapy alone or plus one cycle of ABVD.
Enrici RM; Anselmo AP; Donato V; Falchetto Osti M; Santoro M; Tombolini V; Mandelli F
Haematologica; 1999 Oct; 84(10):917-23. PubMed ID: 10509040
[TBL] [Abstract][Full Text] [Related]
13. Donor screening reduces the isoagglutinin titer in immunoglobulin products.
Siani B; Willimann K; Wymann S; Marques Antunes A; Widmer E
Transfusion; 2015 Jul; 55 Suppl 2():S95-7. PubMed ID: 26174905
[TBL] [Abstract][Full Text] [Related]
14. ABO blood group IgM isoagglutinins interact with tumor-associated O-glycan structures in pancreatic cancer.
Hofmann BT; Stehr A; Dohrmann T; Güngör C; Herich L; Hiller J; Harder S; Ewald F; Gebauer F; Tachezy M; Precht C; Izbicki JR; Bockhorn M; Wagener C; Wolters-Eisfeld G
Clin Cancer Res; 2014 Dec; 20(23):6117-26. PubMed ID: 25320359
[TBL] [Abstract][Full Text] [Related]
15. [A retrospective analysis of the treatment results in Hodgkin's disease in a radiotherapy clinic].
Mjaaland I; Ganser D; Freitag EM; Bohndorf W
Strahlenther Onkol; 1994 Sep; 170(9):516-23. PubMed ID: 7524173
[TBL] [Abstract][Full Text] [Related]
16. Pretreatment determination of isohaemagglutinin titter values in patients with malignant lymphomas and metastatic solid tumors.
Nikolić L; Budisin Z; Jelić S
Med Sci Monit; 2000; 6(1):63-7. PubMed ID: 11208285
[TBL] [Abstract][Full Text] [Related]
17. A study on the immunoglobulin class of the anti-A 1 isoagglutinin.
Plischka H; Schäfer E
J Immunol; 1972 Mar; 108(3):782-4. PubMed ID: 5011756
[No Abstract] [Full Text] [Related]
18. Biophysical analysis of the acute toxicity of radiotherapy in Hodgkin's lymphoma--a comparison between extended field and involved field radiotherapy based on the data of the German Hodgkin Study Group.
Eich HT; Haverkamp U; Engert A; Kocher M; Skripnitchenko R; Brillant C; Sehlen S; Dühmke E; Diehl V; Müller RP
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):860-5. PubMed ID: 15925455
[TBL] [Abstract][Full Text] [Related]
19. [Isoagglutinins of the ABO system in universal blood preparations (KU-ABO) used for exchange transfusions in hemolytic disease of the newborn].
Cwik J
Pediatr Pol; 1985 Sep; 60(9):652-7. PubMed ID: 3831898
[No Abstract] [Full Text] [Related]
20. Serum I-K (immunoconglutinins) in Hodgkin's disease.
Merucii P; Abbolito MR; Barduagni A
Biomedicine; 1975 Feb; 23(2):52-4. PubMed ID: 1167255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
